Overview

Infertility Treatment Market is estimated to value over USD 2.8 billion by 2027 end and register CAGR of over 7.8% during the forecast period 2020-2027.

Infertility Treatment Market Overview:

Increasing incidences of obesity and diabetes, environmental effects like air pollution and changing lifestyle are some integral factors leading to infertility in both women and men. According to the data reported by WHO, over 600 million people are identified as overweight and over 2 million people around the world are diagnosed with obesity. Additionally, workplace stress is another contributing factor for increase in infertility cases.

Hefty investments in research and development has created numerous opportunities for the market to prosper. In a recent study, a female mouse successfully conceives and gave birth to an offspring which was healthy and this was done with a synthetic ovary that was created using a 3D printer. This is considered as a breakthrough research thus leading to eminent infertility treatment for women diagnosed with cancer. One of the co-authors, Alexander Rutz, states that these synthetic ovaries are known as biosynthetic organs as they comprise ovarian cells as well as gelatin. The naturally present ovary was removed and replaced by the biosynthetic ovary so that the mouse shall experience its natural ovulation cycle.

Female infertility treatment segment is projected to account for the largest market share during the forecast period. There has been a rise in the female infertility rates, increasing awareness among women regarding infertility treatments, increase in the number of fertility centres and availability of multiple treatment options are integral factors contributing to the market growth.
Hospitals and surgical clinics segment is expected to exhibit noteworthy growth over the forecast period. Hospitals are firmly bolstered by other departments like neonatal intensive care units. Additionally, hospitals offer a comprehensive maternity treatment even after childbirth. Governmental initiatives to increase the number of multispecialty hospitals with departments to perform infertility treatment procedures like IVF coupled with the increasing number of surgical centres with provisions of surgical procedures for the treatment of infertility is projected to proliferate the market.

FutureWise Key Takeaways:

• Stressful lifestyle and consumption of unhealthy products like tobacco and alcohol are primary reasons of infertility and its soaring rise has increased the demand for market
• The high costs of treatments and societal pressures on patients can significantly affect the market growth especially in the developing economies

Infertility Treatment Market Segmentation:

By Product

• Equipment
  1. Microscopes
  2. Imaging Systems
  3. Sperm Analyzer Systems
  4. Ovum aspiration Pumps
  5. Micromanipulator Systems
  6. Incubators
  7. Gas Analyzers
  8. Laser Systems
  9. Cryo Systems
• Media & Consumables
• Accessories

By Procedure

• In Vitro Fertilization
• Artificial Insemination
  1. Intrauterine Insemination
  2. Intracervical Insemination
  3. Intratubal Insemination
• Fertility Surgery
  1. Laparoscopy
  2. Hysteroscopy
  3. Myomectomy
  4. Laparotomy
  5. Tubal Ligation Reversal
  6. Varicocelectomy
  7. Microsurgical Reconstruction
  8. Vasovasostomy
  9. Vasoepididymostomy
• Others

By Patient Type

• Female Infertility Treatment
• Male Infertility Treatment

By End User

• Fertility Centres
• Hospitals and Surgical Clinics
• Research Institutes
• Cryobanks

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

 Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players 
• Emerging players which are growing rapidly 
• New Entrants

Objectives of the Study:

• To provide with an exhaustive analysis on the shoulder replacement market by product, by procedure, by patient type, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Market Definition 

1.3 Market Scope 

        1.3.1 Markets Covered

        1.3.2 Geographic Scope

        1.3.3 Years Considered for the Study

1.4 Currency 

1.5 Stakeholders 

 

2 Research Methodology 

2.1 Research Data 

        2.1.1 Secondary Data

                 2.1.1.1 Key Data From Secondary Sources

        2.1.2 Primary Data

                 2.1.2.1 Key Data From Primary Sources

                 2.1.2.2 Breakdown of Primaries

        2.1.3 Market Size Estimation

                 2.1.3.1 Product-Based Market Estimation

        2.1.4 Primary Research Validation

2.2 Market Breakdown and Data Triangulation 

        2.2.1 Limitations

        2.2.2 Assumptions for the Study

 

3 Executive Summary  

 

4 Premium Insights 

4.1 Market: Overview 

4.2 Geographic Analysis: Market, By Product 

4.3 Asia Pacific: Market Share, By Procedure (2020) 

4.4 Market, By Patient Type, 2020 vs 2027 (USD Million) 

4.5 Market, By End User, 2020 vs 2027 (USD Million) 

4.6 Geographical Snapshot of the Global Market 

 

5 Market Overview 

5.1 Introduction 

5.2 Market Dynamics 

        5.2.1 Drivers

                 5.2.1.1 Declining Fertility Rate

                 5.2.1.2 Rising Number of Fertility Clinics Worldwide

                 5.2.1.3 Technological Advancements

                            5.2.1.3.1 Advancements in Infertility Treatment Devices

                            5.2.1.3.1 Increase in the Use of Time-Lapse Technology

                 5.2.1.4 Increasing Public-Private Investments, Funds, and Grants

        5.2.2 Restraints

                 5.2.2.1 High Procedural Cost of Assisted Reproductive Techniques in Developed Markets

                 5.2.2.2 Unsupportive Government Regulations

        5.2.3 Opportunities

                 5.2.3.1 Growth Opportunities in Emerging Markets

                            5.2.3.1.1 Improving Healthcare Infrastructure

                            5.2.3.1.2 Increasing Medical Tourism Due to Low Treatment Costs

                 5.2.3.2 Use of Fertility Treatment Options By Single Parents and Same-Sex Couples

        5.2.4 Challenges

                 5.2.4.1 Concerns Related to Art Procedures

                 5.2.4.2 Reduced Efficacy Among Older Women

 

6 Infertility Treatment Market, By Product 

6.1 Introduction 

6.2 Equipment 

        6.2.1 Microscopes

                 6.2.1.1 Growing Technological Advancements in the Field of Microscopy Resulting in the Growing Adoption of Microscopes

        6.2.2 Imaging Systems

                 6.2.2.1 Emergence of Time-Lapse Imaging Systems Driving the Growth of the Infertility Treatment Imaging Systems Market

        6.2.3 Sperm Analyzer Systems

                 6.2.3.1 Automated Sperm Analyzer Systems Permitting Internal and External Quality Control and Better Reproducibility

        6.2.4 Ovum Aspiration Pumps

                 6.2.4.1 Ovum Aspiration Pumps Enable Smooth Collection of Oocytes During Infertility Treatment Procedures

        6.2.5 Micromanipulator Systems

                 6.2.5.1 Micromanipulators are Commonly Used for the Treatment of Male Infertility, Particularly Cases Pertaining to Poor Sperm Quantity/Mobility

        6.2.6 Incubators

                 6.2.6.1 Incubators Play A Vital Role in Embryo Development and Improved Clinical Outcomes

        6.2.7 Gas Analyzers

                 6.2.7.1 Gas Analyzers Contain Multiple Ports Enabling Analysis of Sequential Gas Samples

        6.2.8 Laser Systems

                 6.2.8.1 The Common Applications of Laser Systems Include Treatment of Stress Urinary Incontinence and Vaginal Tightening

        6.2.9 Cryosystems

                 6.2.9.1 Demand for Cryosystems is on the Rise as Women are Seeking to Extend Their Childbearing Years

6.3 Media & Consumables 

        6.3.1 Easy Availability of Culture Media Coupled With the Growing Awareness Among Individuals Driving the Growth of the Media & Consumables Segment

6.4 Accessories 

        6.4.1 Anti-Vibration Tables are Commonly Used for IVF Treatments to Provide A Smooth Workspace During Procedures

 

7 Infertility Treatment Market, By Procedure 

7.1 Introduction 

7.2 Assisted Reproductive Technology 

        7.2.1 in Vitro Fertilization

                 7.2.1.1 Intracytoplasmic Morphologically Selected Sperm Injection

                            7.2.1.1.1 Imsi is Highly Recommended in Patients With A Low Sperm Count and Recurrent Implantation Failure

                 7.2.1.2 Gamete Donation

                            7.2.1.2.1 Increase in the Number of Women Registering as Egg Donors is A Key Factor Aiding Market Growth

        7.2.2 Intracytoplasmic Sperm Injection

                 7.2.2.1 Icsi is A Specialized Form of IVF Involving Fertilization Used Commonly in Male Infertility Treatment Procedures

        7.2.3 Surrogacy

                 7.2.3.1 High Success Rates Guaranteed and Achieved With the Help of Surrogacy are Driving Market Growth

7.3 Artificial Insemination 

        7.3.1 Intrauterine Insemination

                 7.3.1.1 Limited Risk of Complications During Pregnancy and High Success Rates Driving Market Demand for Iui Procedures

        7.3.2 Intracervical Insemination

                 7.3.2.1 Low Cost of Procedure as Compared to Other AI Procedures Leading to Increased Adoption

        7.3.3 Intratubal Insemination

                 7.3.3.1 Better Chances of Successful Pregnancies Using Iti to Drive the Demand for This Procedure

7.4 Fertility Surgery 

        7.4.1 Laparoscopy

                 7.4.1.1 Laparoscopy Allows for the Biopsy of Suspect Growths and Cysts That Hamper Fertility

        7.4.2 Hysteroscopy

                 7.4.2.1 Growing Demand for Minimally Invasive Procedures Driving the Adoption of Hysteroscopy Infertility Treatment Surgeries Globally

        7.4.3 Myomectomy

                 7.4.3.1 Advantages of Myomectomy in Alleviating Problems Caused Due to Fibroids While Preserving Future Fertility to Drive the Demand for This Surgery

        7.4.4 Laparotomy

                 7.4.4.1 Laparotomy is Used in Common Infertility Surgeries That Require Large Exposure to the Reproductive System

        7.4.5 Tubal Ligation Reversal

                 7.4.5.1 Tubal Ligation Reversal is Performed Only in Women Who Still Have A Large Portion of Healthy Fallopian Tube Remaining

        7.4.6 Varicocelectomy

                 7.4.6.1 Adoption of Varicocelectomy is High Among Patients and Results in A High Chance of Improved Fertility With Reduced Complications

        7.4.7 Microsurgical Reconstruction

                 7.4.7.1 Vasovasostomy

                            7.4.7.1.1 Vasovasostomy is A Reversal Surgery Commonly Used in the Treatment of Infertility in Men

                 7.4.7.2 Vasoepididymostomy

                            7.4.7.2.1 Vasoepididymostomy Provides A Higher Pregnancy Rate Than IVF With Icsi

7.5 Other Infertility Treatment Procedures 

 

8 Infertility Treatment Market, By Patient Type 

8.1 Introduction 

8.2 Female Infertility Treatment 

        8.2.1 Increasing Female Infertility Rates to Drive the Growth of the Market

8.3 Male Infertility Treatment 

        8.3.1 Growing Adoption of Male Infertility Treatment Procedures to Provide Potential Growth Opportunities

 

9 Infertility Treatment Market, By End User 

9.1 Introduction 

9.2 Fertility Centers 

        9.2.1 Growing Number of Infertility Treatment Centers Worldwide Driving Growth of This Segment

9.3 Hospitals and Surgical Clinics 

        9.3.1 Initiatives Undertaken By Governments to Increase the Number of Hospitals Equipped to Perform Infertility Treatment Procedures Contributing to Market Growth

9.4 Research Institutes 

        9.4.1 Growing Need for Improving the Clinical Efficacy of Various Infertility Treatment Options Driving Market Growth in Research Institutes

9.5 Cryobanks 

        9.5.1 Increasing Number of Art Procedures Using Donor Sperm and Donor Eggs for Infertility Treatment Driving the Demand for Cryobanks

 

10 Infertility Treatment Market, By Region 

  10.1 Introduction 

  10.2 North America 

          10.2.1 Us

                     10.2.1.1 US to Dominate the Market in North America

          10.2.2 Canada

                     10.2.2.1 Government Initiatives and Legislations for Same-Sex Marriages to Drive Market Growth in Canada

  10.3 Europe 

          10.3.1 Germany

                     10.3.1.1 Favorable Funding Scenario for IVF Treatments in Germany to Drive the Growth of the Market in the Country

          10.3.2 Uk

                     10.3.2.1 Increase in the Number of IVF Cycles in the UK Contributing to Market Growth

          10.3.3 France

                     10.3.3.1 The Art Segment Dominated the Infertility Treatment Procedures Market in France

          10.3.4 Rest of Europe

  10.4 Asia Pacific 

          10.4.1 Japan

                     10.4.1.1 Growing Awareness has Served to Boost the Adoption of IVF Procedures in Japan

          10.4.2 China

                     10.4.2.1 Declining Newborn Population and Birth Rate in China to Drive the Demand for Infertility Treatment Procedures in the Country

          10.4.3 India

                     10.4.3.1 Rising Fertility Medical Tourism Offering High-Growth Opportunities for the Market in India

          10.4.4 Rest of Asia Pacific

  10.5 Rest of the World 

          10.5.1 Latin America

                     10.5.1.1 Latin America to Account for the Largest Share of the Rest of the World Infertility Treatment Market

          10.5.2 Middle East & Africa

                     10.5.2.1 Rising Incidence of Male-Factor Infertility to Drive Market Growth During the Forecast Period

 

11 Competitive Landscape 

  11.1 Overview 

  11.2 Infertility Treatment: Market Share Analysis, 

  11.3 Competitive Scenario 

 

12 Company Profiles 

(Business Overview, Products Offered, Recent Developments, FutureWise View and Key Insights)*

  12.1 Cook Group Incorporated 

  12.2 Esco Micro Pte. Ltd. 

  12.3 Genea Limited 

  12.4 Hamilton Throne, Ltd. 

  12.5 Ihmedical A/S 

  12.6 Irvine Scientific (A Member of Jx Holdings Group) 

  12.7 IVFTech Aps 

  12.8 Kitazato Corporation 

  12.9 Medgyn Products, Inc. 

  12.10 Rocket Medical PLC 

  12.11 Somatex Medical Technologies GmbH 

  12.12 The Baker Company, Inc. 

  12.13 The Cooper Companies, Inc. 

  12.14 Thermo Fisher Scientific 

  12.15 Vitrolife Ab 

  12.16 Zeiss Group 

 

13.  Research Finding and Conclusion  

13 Appendix 

13.1 Research Methodology 

13.2 Research Data Source 

 

Tables

Figures